These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25811302)

  • 1. Prevalence of hepatitis E virus antibodies, Israel, 2009-2010.
    Mor O; Bassal R; Michaeli M; Wax M; Ram D; Cohen-Ezra O; Cohen D; Mendelson E; Ben-Ari Z; Shohat T
    Emerg Infect Dis; 2015 Apr; 21(4):692-4. PubMed ID: 25811302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis E virus seroprevalence in three hyperendemic areas: Nepal, Bangladesh and southwest France.
    Izopet J; Labrique AB; Basnyat B; Dalton HR; Kmush B; Heaney CD; Nelson KE; Ahmed ZB; Zaman K; Mansuy JM; Bendall R; Sauné K; Kamar N; Arjyal A; Karkey A; Dongol S; Prajapati KG; Adhikary D
    J Clin Virol; 2015 Sep; 70():39-42. PubMed ID: 26305817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis E virus in children from Northeast of Argentina.
    Martínez AP; Pereson MJ; Pérez PS; Baeck MI; Mandó P; López Saubidet I; Di Lello FA
    J Med Virol; 2021 Jun; 93(6):4015-4017. PubMed ID: 32639583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-hepatitis E virus antibody prevalence in French expatriate workers.
    Vernier M; Rossi-Tamisier M; Richet H; Brouqui P; Parola P; Bouamri Y; Colson P; Gautret P
    Int J Infect Dis; 2013 Nov; 17(11):e1082-4. PubMed ID: 23953700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low prevalence of anti-hepatitis E virus IgG antibodies in Tepehuanos in Mexico.
    Alvarado-Esquivel C; Gutierrez-Martinez VD; Ramírez-Valles EG; Sifuentes-Alvarez A
    Ann Hepatol; 2020; 19(2):186-189. PubMed ID: 31771821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis E seroprevalence in the United States: Results for immunoglobulins IGG and IGM.
    Cangin C; Focht B; Harris R; Strunk JA
    J Med Virol; 2019 Jan; 91(1):124-131. PubMed ID: 30168589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigation of the hepatitis E virus seroprevalence in cases admitted to Hacettepe University Medical Faculty Hospital].
    Aydın NN; Ergünay K; Karagül A; Pınar A; Us D
    Mikrobiyol Bul; 2015 Oct; 49(4):554-64. PubMed ID: 26649413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis E in hemodialysis and kidney transplant patients in south-east Italy.
    Scotto G; Aucella F; Grandaliano G; Martinelli D; Querques M; Gesuete A; Infante B; Carri PD; Massa S; Salatino G; Bulla F; Fazio V
    World J Gastroenterol; 2015 Mar; 21(11):3266-73. PubMed ID: 25805933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological evidence for hepatitis E virus infection in Israel.
    Karetnyi YV; Favorov MO; Khudyakova NS; Weiss P; Bar-Shani S; Handsher R; Aboudy Y; Varsano N; Schwartz E; Levin E
    J Med Virol; 1995 Mar; 45(3):316-20. PubMed ID: 7775954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High seroprevalence of hepatitis E virus in rabbit slaughterhouse workers.
    Geng Y; Zhao C; Geng K; Wang C; Wang X; Liu H; Wang Y
    Transbound Emerg Dis; 2019 Mar; 66(2):1085-1089. PubMed ID: 30661292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decline in hepatitis E virus antibody prevalence in the United States from 1988-1994 to 2009-2010.
    Teshale EH; Denniston MM; Drobeniuc J; Kamili S; Teo CG; Holmberg SD
    J Infect Dis; 2015 Feb; 211(3):366-73. PubMed ID: 25147277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and characteristics of hepatitis E virus infection in kidney transplant recipients: A single-center experience in Japan.
    Nanmoku K; Owada Y; Oshiro Y; Kurosawa A; Kubo T; Shinzato T; Shimizu T; Kimura T; Sakuma Y; Ishikawa N; Ohkohchi N; Okamoto H; Yagisawa T
    Transpl Infect Dis; 2019 Apr; 21(2):e13033. PubMed ID: 30481402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of anti-hepatitis E antibodies and antigens among HIV-infected patients in Fars Province, southern Iran.
    Shahriarirad R; Erfani A; Rastegarian M; Zeighami A; Arefkhah N; Ghorbani F; Sarvari J; Sarkari B
    Virol J; 2020 Jul; 17(1):109. PubMed ID: 32680534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A sero-epidemiological study of hepatitis E among general population in Shandong Province of China in 2014].
    Yan BY; Zhang L; Lyu JJ; Feng Y; Liu JY; Wu WL; Song LZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):587-592. PubMed ID: 28693081
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis E virus: Western Cape, South Africa.
    Madden RG; Wallace S; Sonderup M; Korsman S; Chivese T; Gavine B; Edem A; Govender R; English N; Kaiyamo C; Lutchman O; van der Eijk AA; Pas SD; Webb GW; Palmer J; Goddard E; Wasserman S; Dalton HR; Spearman CW
    World J Gastroenterol; 2016 Nov; 22(44):9853-9859. PubMed ID: 27956810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pork consumption and seroprevalence of hepatitis E virus,Thailand, 2007-2008.
    Gonwong S; Chuenchitra T; Khantapura P; Islam D; Sirisopana N; Mason CJ
    Emerg Infect Dis; 2014 Sep; 20(9):1531-4. PubMed ID: 25148245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of anti-hepatitis E virus antibodies in outpatients with chronic liver disease in a university medical center in Germany.
    Schulz M; Beha D; Plehm K; Zöllner C; Hofmann J; Schott E
    Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1431-1436. PubMed ID: 27552296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Special Risk Group for Hepatitis E Infection: The First Record of North Cyprus.
    Süer K; Güvenir M; Aykaç A
    Pol J Microbiol; 2018; 67(4):525-528. PubMed ID: 30550239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis E virus IgG seroprevalence in HIV patients and blood donors, west-central Poland.
    Bura M; Łagiedo M; Michalak M; Sikora J; Mozer-Lisewska I
    Int J Infect Dis; 2017 Aug; 61():20-22. PubMed ID: 28576599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of anti-hepatitis E virus antibodies among blood donors in central Italy, February to March 2014.
    Lucarelli C; Spada E; Taliani G; Chionne P; Madonna E; Marcantonio C; Pezzotti P; Bruni R; La Rosa G; Pisani G; Dell'Orso L; Ragone K; Tomei C; Ciccaglione AR
    Euro Surveill; 2016 Jul; 21(30):. PubMed ID: 27494608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.